尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the detailed record of transactions filed by Sems Lloyd, 董事. Insider active across 1 company, notably Cyclacel Pharmaceuticals, Inc.. Aggregated, 2 disclosures have been recorded. Activity tracked since 15 June 2021. The latest transaction was disclosed on 14 June 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Lloyd Sems is a Director at Cyclacel Pharmaceuticals, Inc. In this role, he participates in the governance of the company and strategic decision-making. Lloyd brings his expertise and advice to help guide Cyclacel's direction, ensuring that the company meets its objectives and commitments to its stakeholders.